In March 2008, the European Commission granted marketing authorization for dabigatran etexilate (Pradaxa; Boehringer Ingelheim), a direct thrombin inhibitor, for the prevention of venous ...

News, June 23, 2023 Alert Dabigatran Recalled Over Potential Carcinogen Ascend Labs issues voluntary nationwide recall of dabigatran etexilate capsules (75/150 mg) after detection of unacceptable ...